. Natural products research during the last few decades has yielded thousands of novel organisms from the marine environment. The bioassays guiding these isolations typically have been based on antimicrobial, antitumor, antiviral, or antiinflammatory actvities. Little has been done to explore the oceans for compounds with activity against HIV and AIDS OI. Additionally, because of the limits associated with the conventional Self-Contained Underwater Breathing Apparatus (SCUBA), the majority of the compounds characterized from the marine environment are the results of shallow-water collections (-30 meters). The value of mass screening of complex extracts of natural products coupled with bioactivity-guided fractionation and compound identification for the discovery of new natural product chemotypes is well known. The primary focus of this application is on the isolation and characterization of new chemotypes for the potential treatment of AIDS and AIDS-related opportunistic infections (OI), and the applicant will collect and screen marine samples in relevant bioassays. Samples will be obtained from depths of 0 to -800 meters, and among the collection methods used will be CCUBA (Closed Circuit Underwater Breathing Apparatus), which will permit longer and deeper dives than possible by SCUBA, and will allow the applicant to work on previously unexplored marine benthic species. Active extracts of organisms will be isolated using various chromatographic techniques inclusive of HPLC, and chemical structures of biologically active secondary metabolites will be determined through spectroscopic and chemical methods, with special emphasis on two- dimensional NMR techniques. Additional quantities of particularly promising compounds that are required for in vivo testing will be obtained via synthesis, semi-synthesis, or repeated isolation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29AI036596-03
Application #
2390408
Study Section
AIDS and Related Research Study Section 4 (ARRD)
Project Start
1995-04-01
Project End
2000-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Mississippi
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
City
University
State
MS
Country
United States
Zip Code
38677
Sayed, Khalid A El; Khalil, Ashraf A; Yousaf, Muhammad et al. (2008) Semisynthetic studies on the manzamine alkaloids. J Nat Prod 71:300-8
Hu, Jin-Feng; Schetz, John A; Kelly, Michelle et al. (2002) New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea. J Nat Prod 65:476-80
Hu, Jin-Feng; Kelly, Michelle; Hamann, Mark T (2002) 26-Nor-25-isopropyl-ergosta-5,7,22E-trien-3beta-ol: a new C(29) sterol from the sponge Agelas sceptrum from Jamaica. Steroids 67:743-7
El Sayed, K A; Hamann, M T; Hashish, N E et al. (2001) Antimalarial, antiviral, and antitoxoplasmosis norsesterterpene peroxide acids from the Red Sea sponge Diacarnus erythraeanus. J Nat Prod 64:522-4
Gochfeld, D J; Hamann, M T (2001) Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp. J Nat Prod 64:1477-9
El Sayed, K A; Kelly, M; Kara, U A et al. (2001) New manzamine alkaloids with potent activity against infectious diseases. J Am Chem Soc 123:1804-8
Ross, S A; Weete, J D; Schinazi, R F et al. (2000) Mololipids, a new series of anti-HIV bromotyramine-derived compounds from a sponge of the order verongida. J Nat Prod 63:501-3
Ross, S A; el Sayed, K A; el Sohly, M A et al. (1997) Phytochemical analysis of Geigeria alata and Francoeuria crispa essential oils. Planta Med 63:479-82
el Sayed, K A; Hamann, M T (1996) A new norcembranoid dimer from the red sea soft coral Sinularia gardineri. J Nat Prod 59:687-9